AnaptysBio Files 2024 10-K

Ticker: ANAB · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1370053

Anaptysbio, Inc 10-K Filing Summary
FieldDetail
CompanyAnaptysbio, Inc (ANAB)
Form Type10-K
Filed DateFeb 27, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

ANAB 10-K filed: full year financials for 2024 out. Check it.

AI Summary

AnaptysBio, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Diego, CA, operates in the pharmaceutical preparations sector. The filing details its financial performance and business operations for the year, including information on its fiscal year end and incorporation state.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of AnaptysBio's financial health and strategic direction for the fiscal year 2024, crucial for understanding its current market position and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, AnaptysBio faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
  • 2025-02-27 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

  • ANAPTYSBIO, INC (company) — Filer of the 10-K
  • 2024-12-31 (date) — Fiscal year end
  • 2025-02-27 (date) — Filing date
  • San Diego, CA (location) — Company headquarters
  • 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations

FAQ

What is AnaptysBio's primary business focus as indicated by its SIC code?

AnaptysBio's primary business focus is in Pharmaceutical Preparations, as indicated by its SIC code 2834.

When did AnaptysBio file its 10-K for the fiscal year ending December 31, 2024?

AnaptysBio filed its 10-K for the fiscal year ending December 31, 2024, on February 27, 2025.

Where is AnaptysBio, Inc. headquartered?

AnaptysBio, Inc. is headquartered in San Diego, CA.

What is the SEC file number for AnaptysBio's 10-K filing?

The SEC file number for AnaptysBio's 10-K filing is 001-37985.

What was the previous name of AnaptysBio, Inc. before its name change on August 28, 2008?

Before its name change on August 28, 2008, AnaptysBio, Inc. was formerly known as ANAPTYS BIOSCIENCES INC.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding ANAPTYSBIO, INC (ANAB).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.